Associated Papers
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.
Stevers NO et al.
Molecular Cell, 2025
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.
Orzan F et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
36648487 (PubMed )
Supplement: ccr-22-2903_supplementary_information_1_suppms1.pdf
Co-Occurrence of Hotspot Point Mutation and Novel Deletion Mutation of TERT Promoter in Solid Variant Papillary Thyroid Carcinoma in a Patient with Synchronous Esophageal Cancer.
Han J et al.
Diagnostics (basel, Switzerland), 2020
Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma.
Pezzuto F et al.
Infectious Agents and Cancer, 2017
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
Liu J et al.
Genetic Testing and Molecular Biomarkers, 2016
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Nault JC et al.
Nature Communications, 2013
Select a paper to view details